Vandana Jain, MD
Endocrinology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 3 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Jain’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
9 of 9 plans
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
State licence records
1 licence
- Washington MD.MD.60810912Physician And Surgeon License · since 2018 · expires 2021-03-04ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$18,684
Medicare paid this office $18,684 for 200 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 136 | $12,541 | $72 |
| New patient visit (45+ min) | 25 | $3,012 | $120 |
| New patient visit (30+ min) | 23 | $1,335 | $58 |
| Telephone medical discussion with physician, 5-10 minutes | 28 | $794 | $27 |
| Short return visit (20+ min) | 11 | $539 | $49 |
Who their Medicare patients are
200 Original Medicare patients in 2024. Average age 74 · Under 65 12% · 85 and older 17% · Women 79% · Also on Medicaid 80% · Health risk score 1.38. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 72% · Diabetes 34% · Depression 17% · Chronic kidney disease 16% · Heart failure 14% · Atrial fibrillation 14% · Coronary heart disease 13% · Cancer 12% · COPD 10% · Dementia 10% · Stroke 7%.
The office billed $194,589, Medicare allowed $27,811 and paid $18,684; for 271 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 200 | 271 | 74 | 1.38 | $194,589 | $18,684 |
| 2023 | 204 | 312 | 74 | 1.39 | $165,890 | $16,958 |
| 2022 | 145 | 196 | 74 | 1.31 | $72,724 | $7,833 |
| 2021 | 162 | 224 | 74 | 1.54 | $83,348 | $13,485 |
| 2020 | 103 | 146 | 70 | 1.74 | $48,484 | $6,304 |
| 2019 | 131 | 213 | 71 | 1.71 | $65,212 | $9,031 |
| 2018 | 76 | 163 | 73 | 1.53 | $33,914 | $13,919 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Short return visit (20+ min) | 117 | $6,814 | $46 |
| Return visit (30+ min) | 41 | $3,407 | $79 |
| New patient visit (30+ min) | 41 | $2,672 | $65 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $2,168 | $45 |
2022: 5 services
| Short return visit (20+ min) | 48 | $2,524 | $46 |
| Return visit (30+ min) | 32 | $2,468 | $75 |
| Short return visit | 59 | $1,685 | $24 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $623 | $35 |
| Telephone medical discussion with physician, 5-10 minutes | 18 | $398 | $22 |
2021: 6 services
| Telephone medical discussion with physician, 11-20 minutes | 73 | $4,345 | $55 |
| Short return visit (20+ min) | 45 | $2,583 | $55 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,863 | $98 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,047 | $81 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | $402 | $31 |
| Short return visit | 17 | $369 | $22 |
2020: 4 services
| Telephone medical discussion with physician, 11-20 minutes | 30 | $1,378 | $46 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,345 | $103 |
| Telephone medical discussion with physician, 5-10 minutes | 39 | $868 | $21 |
| Short return visit (20+ min) | 20 | $280 | $14 |
2019: 6 services
| Short return visit (20+ min) | 36 | $1,732 | $41 |
| New patient visit (30+ min) | 21 | $1,242 | $59 |
| Short return visit (20+ min) | 20 | $1,061 | $48 |
| Return visit (30+ min) | 18 | $817 | $45 |
| Short return visit | 19 | $478 | $23 |
| Blood glucose (sugar) test performed by hand-held instrument | 26 | $106 | $3 |
2018: 6 services
| New patient visit (60+ min) | 23 | $3,641 | $158 |
| New patient visit (45+ min) | 26 | $3,542 | $136 |
| Long return visit (40+ min) | 20 | $2,617 | $125 |
| Return visit (30+ min) | 20 | $1,613 | $81 |
| Short return visit (20+ min) | 17 | $1,153 | $61 |
| Blood glucose (sugar) test performed by hand-held instrument | 30 | $119 | $3 |
Medicaid work
$13,366 in 2024
Medicaid paid $13,366 for 3,040 billed services this clinician did in 2024, up to 101 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 694 | $9,999 |
| New patient visit (30+ min) | 115 | $1,920 |
| New patient visit (45+ min) | 45 | $827 |
| Short return visit (20+ min) | 62 | $619 |
| Pain severity quantified; no pain present (COA) (ONC) | 28 | $0 |
| Medication list documented in medical record (COA) | 637 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 15 | $0 |
| MOST RECENT LDL-C <100 MG/DL | 12 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 460 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 151 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 113 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 530 | $0 |
| 2024 | 3,040 | 13 | 101 | $13,366 |
| 2023 | 1,237 | 9 | 85 | $6,531 |
| 2022 | 540 | 4 | 36 | $3,880 |
| 2021 | 521 | 3 | 51 | $3,162 |
| 2020 | 80 | 2 | 31 | $399 |
| 2019 | 182 | 3 | 29 | $708 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 674 | $3,973 |
| Return visit (30+ min) | 130 | $1,278 |
| New patient visit (30+ min) | 99 | $825 |
| Thyroid stimulating hormone (TSH) | 14 | $267 |
| Short return visit | 29 | $189 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 78 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 76 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 24 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 113 | $0 |
2022
| Short return visit (20+ min) | 213 | $1,726 |
| Short return visit | 262 | $1,363 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 52 | $594 |
| Return visit (30+ min) | 13 | $197 |
2021
| Short return visit (20+ min) | 388 | $2,594 |
| Short return visit | 120 | $471 |
| Return visit (30+ min) | 13 | $97 |
2020
| Short return visit (20+ min) | 59 | $257 |
| Short return visit | 21 | $142 |
2019
| Short return visit (20+ min) | 94 | $454 |
| Short return visit | 63 | $205 |
| New patient visit (30+ min) | 25 | $49 |
Drugs they prescribed that Part D paid
$388,313
Pharmacies billed $388,313 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 559) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
325 generic and 213 brand-name prescriptions · $388,313 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Prolia | 131 | $198,712 | $1,517 |
| Forteo | 26 | $99,557 | $3,829 |
| Teriparatide | 32 | $65,129 | $2,035 |
| Levothyroxine | 127 | $1,621 | $13 |
| Ultra-Fine Mini Pen Needle | 17 | $905 | $53 |
See all 9 drugs
| Prolia | 131 | $198,712 | $1,517 |
| Forteo | 26 | $99,557 | $3,829 |
| Teriparatide | 32 | $65,129 | $2,035 |
| Levothyroxine | 127 | $1,621 | $13 |
| Ultra-Fine Mini Pen Needle | 17 | $905 | $53 |
| Methimazole | 56 | $758 | $14 |
| Hydrocortisone | 17 | $748 | $44 |
| Calcitriol | 11 | $221 | $20 |
| Hydrochlorothiazide | 16 | $14 | $1 |
Year by year
| 2024 | 559 | 183 | 0% (0) | 38% | $388,313 |
| 2023 | 430 | 184 | 0% (0) | 41% | $338,782 |
| 2022 | 319 | 123 | 0% (0) | 35% | $136,094 |
| 2021 | 185 | 97 | 0% (0) | 31% | $77,775 |
| 2020 | 157 | 52 | 0% (0) | None | $78,577 |
| 2019 | 393 | 108 | 0% (0) | 52% | $162,597 |
| 2018 | 720 | 115 | 0% (0) | 38% | $133,880 |
| 2017 | 489 | 79 | 0% (0) | 39% | $85,718 |
| 2016 | 139 | 29 | 0% (0) | None | $9,404 |
| 2015 | 62 | None | 0% (0) | 35% | $4,362 |
| 2014 | 88 | 15 | None | None | $14,535 |
| 2013 | 80 | None | 0% (0) | 49% | $6,920 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Prolia | 116 | $187,033 | $1,612 |
| Forteo | 15 | $62,666 | $4,178 |
| Levothyroxine | 83 | $1,760 | $21 |
| Methimazole | 69 | $1,120 | $16 |
| Alendronate | 14 | $182 | $13 |
| Dexamethasone | 18 | $13 | $1 |
2022: 5 drugs
| Prolia | 74 | $103,774 | $1,402 |
| Levothyroxine | 55 | $1,849 | $34 |
| Methimazole | 57 | $939 | $16 |
| Ultra-Fine Mini Pen Needle | 12 | $671 | $56 |
| Alendronate | 11 | $90 | $8 |
2021: 3 drugs
| Prolia | 50 | $63,488 | $1,270 |
| Levothyroxine | 30 | $742 | $25 |
| Methimazole | 49 | $625 | $13 |
2020: 3 drugs
| Prolia | 28 | $32,629 | $1,165 |
| Levothyroxine | 12 | $320 | $27 |
| Methimazole | 27 | $319 | $12 |
2019: 10 drugs
| Januvia | 21 | $16,176 | $770 |
| Novolog Flexpen | 13 | $15,414 | $1,186 |
| Lantus Solostar | 34 | $15,199 | $447 |
| Prolia | 13 | $14,492 | $1,115 |
| Humalog Kwikpen U-100 | 20 | $12,920 | $646 |
| Levothyroxine | 42 | $767 | $18 |
| Methimazole | 24 | $321 | $13 |
| Glimepiride | 20 | $285 | $14 |
| Metformin Hcl Er | 19 | $240 | $13 |
| Metformin | 13 | $176 | $14 |
2018: 20 drugs
| Sensipar | 17 | $28,158 | $1,656 |
| Januvia | 40 | $21,588 | $540 |
| Novolog Flexpen | 32 | $15,753 | $492 |
| Levemir Flextouch | 33 | $11,103 | $336 |
| Janumet | 20 | $8,465 | $423 |
| Humalog Kwikpen U-100 | 16 | $6,289 | $393 |
| Lantus Solostar | 18 | $6,145 | $341 |
| Basaglar Kwikpen U-100 | 16 | $5,117 | $320 |
| Levothyroxine | 80 | $1,391 | $17 |
| Easy Comfort Pen Needles | 15 | $795 | $53 |
| Ultra-Fine Nano Pen Needle | 13 | $751 | $58 |
| Repaglinide | 27 | $688 | $25 |
| Alcohol Prep Pads | 11 | $463 | $42 |
| Hydrocortisone | 23 | $393 | $17 |
| Methimazole | 26 | $333 | $13 |
| Atorvastatin | 30 | $267 | $9 |
| Alendronate | 28 | $192 | $7 |
| Metformin | 41 | $135 | $3 |
| Gabapentin | 14 | $80 | $6 |
| Simvastatin | 23 | $55 | $2 |
2017: 13 drugs
| Sensipar | 16 | $23,459 | $1,466 |
| Novolog Flexpen | 29 | $13,974 | $482 |
| Januvia | 27 | $13,010 | $482 |
| Janumet | 18 | $9,050 | $503 |
| Lantus Solostar | 19 | $6,448 | $339 |
| Levothyroxine | 76 | $1,200 | $16 |
| Repaglinide | 19 | $892 | $47 |
| Hydrocortisone | 19 | $381 | $20 |
| Alendronate | 30 | $211 | $7 |
| Methimazole | 16 | $179 | $11 |
| Metformin | 30 | $148 | $5 |
| Atorvastatin | 16 | $142 | $9 |
| Amlodipine Besylate | 11 | $34 | $3 |
2016: 2 drugs
| Levothyroxine | 15 | $275 | $18 |
| Metformin | 12 | $32 | $3 |
Money from drug and device companies
$20 in 2025
| 2025 | 1 | 1 | None | $20 |
| 2024 | 1 | 1 | None | $27 |
| 2023 | 1 | 1 | None | $24 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sanofi Pasteur | Flublok Quadrivalent Northern Hemisphere | $20 | 1 payment
|
See the published payment
| Sanofi Pasteur | Meals · 2025-02-28 | Flublok Quadrivalent Northern Hemisphere | $20 |
See earlier years (2024, 2023)
2024: $27
| Sanofi Pasteur | Flublok Quadrivalent Northern Hemisphere | $27 | 1 payment
|
2023: $24
| Sanofi Pasteur | Fluzone Quadrivalent Northern Hemisphere | $24 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1457791683
- Licence
- WA 60810912Washington MD.MD.60810912: Expired
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 11011 Meridian Ave N Ste 201, Seattle, WA, 98133
- NPI first listed
- 2013-07-02
- NPI last updated
- 2018-07-06
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 450 Clarkson Ave, Brooklyn, NY, 11203